Showing results (561-570 of 893) with videos related to
Sort By:
Pageof 90
Journal of the American College of Cardiology|June 6, 2020
Recovery of Left Ventricular Systolic Function and Clinical Outcomes in Young Adults With Myocardial InfarctionWanda Y Wu, David W Biery, Avinainder Singh, et al.Revista Espanola De Cardiologia|March 15, 2011
[Comparative prognostic value of plasma and urinary N-terminal pro-B-type natriuretic peptide in patients with acute destabilized heart failure]Sergio Manzano-Fernández, James L Januzzi, Miguel Boronat García, et al.Journal of the American College of Cardiology|September 24, 2021
Prognostic Importance of NT-proBNP and Effect of Empagliflozin in the EMPEROR-Reduced TrialJames L Januzzi, Faiez Zannad, Stefan D Anker, et al.Circulation. Cardiovascular Quality and Outcomes|December 10, 2015
Effects of Optimism and Gratitude on Physical Activity, Biomarkers, and Readmissions After an Acute Coronary Syndrome: The Gratitude Research in Acute Coronary Events StudyJeff C Huffman, Eleanor E Beale, Christopher M Celano, et al.Diabetes, Obesity & Metabolism|August 24, 2018
Management of patients with diabetes and heart failure with reduced ejection fraction: An international comparisonSuzanne V Arnold, Jonathan Yap, Carolyn S P Lam, et al.JACC. Heart Failure|October 25, 2024
Uric Acid and SGLT2 Inhibition With Empagliflozin in Heart Failure With Preserved Ejection Fraction: The EMPEROR-Preserved TrialWolfram Doehner, Stefan D Anker, Javed Butler, et al.European Journal of Heart Failure|November 15, 2023
Growth differentiation factor-15 and the effect of empagliflozin in heart failure: Findings from the EMPEROR programJoão Pedro Ferreira, Milton Packer, Javed Butler, et al.Clinical Trials (London, England)|January 13, 2017
The Positive Emotions after Acute Coronary Events behavioral health intervention: Design, rationale, and preliminary feasibility of a factorial design studyJeffery C Huffman, Ariana M Albanese, Kirsti A Campbell, et al.European Heart Journal|May 23, 2008
Adequacy of endogenous erythropoietin levels and mortality in anaemic heart failure patientsPeter van der Meer, Dirk J Lok, James L Januzzi, et al.Journal of the American College of Cardiology|September 19, 2006
Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failureRoland R van Kimmenade, James L Januzzi, Patrick T Ellinor, et al.Pageof 90